A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated eIF4E.
Haematologica
; 100(1): e7-9, 2015 Jan.
Article
in En
| MEDLINE
| ID: mdl-25425688
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Antineoplastic Combined Chemotherapy Protocols
/
Biomarkers, Tumor
/
Salvage Therapy
/
Drug Resistance, Neoplasm
/
Eukaryotic Initiation Factor-4E
/
Neoplasm Recurrence, Local
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Haematologica
Year:
2015
Document type:
Article